Deregulated expression of DP1 induces epidermal proliferation and enhances skin carcinogenesis

Molecular Carcinogenesis

Volumn 31, Issue 2, 2001, Pages 90-100

  Nomura, Masaaki ^a   Kaji, Akira ^a   Wei Ya, Ma ^a   Miyamoto, Ken Ichi ^b   Dong, Zigang ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

Carcinogenesis; Cell cycle; E2F

Indexed keywords

GENE PRODUCT; POLYPEPTIDE; PROTEIN DP1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DRTF1; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; ASSAY; CELL CYCLE; CELL HYPERPLASIA; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; EPIDERMIS; GENE CONTROL; GENE EXPRESSION; GENE OVEREXPRESSION; KERATINOCYTE; MOUSE; NONHUMAN; ONTOGENY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN MOTIF; RETINOBLASTOMA; SKIN CARCINOGENESIS; SKIN TUMOR; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; BLOTTING, NORTHERN; BLOTTING, WESTERN; BROMODEOXYURIDINE; CELL CYCLE PROTEINS; CELL DIVISION; CELL NUCLEUS; EPIDERMIS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KERATINS; MICE; MICE, TRANSGENIC; PROMOTER REGIONS (GENETICS); PROTEIN STRUCTURE, TERTIARY; SKIN; SKIN NEOPLASMS; TIME FACTORS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS; TRANSGENES;

MUS MUSCULUS;

EID: 0034960989     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/mc.1044     Document Type: Article

References (38)

1. The hallmarks of cancer
2. Distinct roles for E2F proteins in cell growth control and apoptosis
3. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells
4. Expression of transcription factor E2F1 induces quiescent cells to enter S phase
5. INK4A-mediated growth suppression
6. The molecular basis of E2F-1/DP-1-induced S-phase entry and apoptosis
7. E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo
8. E2F-4, a new member of the E2F transcription factor family, interacts with p107
9. Ocogenic capacity of the E2F1 gene
10. Proto-oncogenic properties of the DP family of proteins
11. Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53
12. E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model
13. Overexpression of E2F-1 in rat embryo fibroblasts leads to neoplastic transformation
14. Multiple members of the E2F transcription factor family are the products of oncogenes
15. Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos
16. Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rbl(+/-) mice
17. A new component of the transcription factor DRTF1/E2F
18. DP-1: A cell cycle-regulated and phosphorylated component of transcription factor DRTF1/E2F which is functionally important for recognition by pRb and the adenovirus E4 orf 6/7 protein
19. In vivo association of E2F and DP family proteins
20. Functional synergy between DP-1 and E2F-1 in the cell cycle-regulating transcription factor DRTF1/E2
21. Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation
22. Binding to DNA and the retinoblastoma gene product promoted by complex formation of different E2F family members
23. Nuclear localization of DP and E2F transcription factors by heterodimeric partners and retinoblastoma protein family members
24. E2F-1-induced p53-independent apoptosis in transgenic mice
25. Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development
26. E2F4 and E2F1 have similar proliferative properties but different apoptotic and oncogenic properties in vivo
27. Sequences 5′ of the bovine keratin 5 gene direct tissue-and-cell-type-specific expression of a lacz gene in the adult and during development
28. E2F activity is regulated by cell cycle-dependent changes in subcellular localization
29. Association with E2F-1 governs intracellular trafficking and polyubiquitination of DP-1
30. The subcellular localization of E2F-4 is cell-cycle dependent
31. Induction of S-phase entry by E2F transcription factors depends on their nuclear localization
32. The E2F transcription factor is a cellular target for the RB protein
33. Microinjected c-myc as a competence factor
34. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase
35. Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation
36. Specific regulation of E2F family members by cyclin-dependent kinases
37. Degradation of E2F by the ubiquitin-proteasome pathway: Regulation by retinoblastoma family proteins and adenovirus transforming proteins
38. Regulation of E2F through ubiquitin-proteasome-dependent degradation: Stabilization by the pRB tumor suppressor protein